• One of the UAE’s leading private healthcare companies will support the UAE Government’s ‘Project of the 50’ initiative to boost number of Emiratis in the private sector

Dubai – Mediclinic Middle East, one of the UAE’s leading private hospital groups with seven hospitals and more than 20 outpatient clinics across Dubai, Abu Dhabi and Al Ain, has today announced an initiative to attract 1,000 Emiratis into its workforce to achieve targeted UAE national representation in the private and semi-government sectors.

Mediclinic Middle East already has a number of Emirati employees in both clinical and non-clinical job roles, and actively seeks to attract Emiratis in a range of medical and allied health positions through established educational affiliations with institutions such as the Mohammed Bin Rashid University of Medical and Health Sciences, Fatima College of Health Sciences, United Arab Emirates University, Al Ain University and Abu Dhabi University.  The new scheme, however, will be broadened to include a learning academy for young UAE nationals to develop and prepare themselves for a variety of roles across the group, with visible career progression linked to performance standards, a customised mentorship and orientation programme for Emirati joiners, and the establishment of new internship programmes in areas such as Pharmacy, Nursing and Dentistry.

Ahmed Ali, Executive Director at Mediclinic Middle East, said: “I am delighted that the UAE government, under the leadership of His Highness the President, His Highness the Vice-President and His Highness the Crown Prince of Abu Dhabi, announced this initiative. I have worked for Mediclinic since 1997, and have witnessed first-hand how one of Mediclinic’s main priorities has always been to recruit UAE nationals into its team.  As Mediclinic, we are keen to attract and develop the huge talent that lies within the Emirati community, and to support the efforts of the UAE government to expand the opportunities for its citizens.  I am sure that this initiative will bring significant added value to Mediclinic Middle East’s business and we look forward to the successful implementation of our plan to bring many more UAE nationals into the company.”

David Hadley, Chief Executive Officer of Mediclinic Middle East, added: “Mediclinic has worked hard over the past few years to ensure that Emiratis view a career at Mediclinic as long-term and sustainable, but we are now better positioned to recruit and retain UAE nationals in the private sector than ever before.  I am confident that we can deliver on our target of a workforce of 1,000 plus UAE nationals and I am excited that Mediclinic can continue to give back to the country in which it has played an active and integral part for many years.”

Mediclinic is initially seeking UAE national applicants in the clinical areas of nursing, laboratory, pharmacy, medical imaging, physiotherapy and medical doctors.  Non-clinical opportunities are available to UAE nationals in the areas of general healthcare administration, client engagement, finance, insurance and human resources.  If any Emirati would like to apply, please register your CV on the following link:  https://bit.ly/3bgyzwR 

-Ends-

About Mediclinic Middle East

Mediclinic Middle East is part of Mediclinic International plc, a London Stock Exchange (LSE)-listed private healthcare group with three operating divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates. Mediclinic International also holds a 29.9% interest in Spire Healthcare Group plc, a LSE-listed and UK-based private healthcare group.

The foundation of Mediclinic lies in the application of rigorous science to improve the lives of patients, through the use of state-of-the-art treatments and technologies to care for patients in an evidence-based environment.

Mediclinic Middle East operates seven hospitals and more than 20 clinics in the UAE with over 900 inpatient beds.

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.